Blandine Meniel-Seon
Orsay, 91190, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2.
Journal: Scientific reports
Published: October 13, 2025
Unifying the Absolute Configuration of Dibenzopyrrocoline Alkaloids with Relative Configuration Revision of Cryptowolinol and Description of Isocryptaustoline from Cryptocarya oubatchensis.
Journal: Journal of natural products
Published: March 31, 2025
Five new cassane diterpenes from the seeds and bark of Erythrophleum suaveolens.
Journal: Fitoterapia
Published: July 03, 2020
Streamlined targeting of Amaryllidaceae alkaloids from the bulbs of Crinum scillifolium using spectrometric and taxonomically-informed scoring metabolite annotations.
Journal: Phytochemistry
Published: April 24, 2020
Three novel non-nitrogenous cassane diterpenoids from Erythrophleum suaveolens (Guill. et Perr.) Brenan (Fabaceae).
Journal: Natural product research
Published: August 08, 2019
Spectroscopic data of new cassane diterpenoids from the root bark of Erythrophleum suaveolens.
Journal: Data in brief
Published: April 10, 2019
Correction to Identification of a Novel 1,4,8-Triazaphenanthrene Derivative as a Neuroprotectant for Dopamine Neurons Vulnerable in Parkinson's Disease.
Journal: ACS chemical neuroscience
Published: September 28, 2017
Identification of a Novel 1,4,8-Triazaphenanthrene Derivative as a Neuroprotectant for Dopamine Neurons Vulnerable in Parkinson's Disease.
Journal: ACS chemical neuroscience
Published: February 01, 2017
New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease Models.
Journal: Journal of medicinal chemistry
Published: June 25, 2016
Bioactive phloroglucinols from Mallotus oppositifolius.
Journal: Fitoterapia
Published: March 31, 2015
Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease.
Journal: European journal of medicinal chemistry
Published: August 26, 2014
Last Updated: 09/26/2026